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Limited attention to tackling neglected tropical diseases (NTDs) through the lenses of gender, equity, ethnicity
and human rights inadvertently undermines progress due to the exclusion of subgroups in populations living in
conditions of vulnerability. Supporting national NTD programmes to make equity analysis part of their routine
activities and revitalising intersectoral collaboration will be essential to achieve effective, sustainable service
delivery with a person-centred approach. Gender, equity, human rights and ethnic equality for NTD programmes
should therefore be incorporated in multisectoral engagements.
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The 2030 Agenda for Sustainable Development emphasises the
importance of ensuring equitable health outcomes and health-
care delivery. Transformative in its gender-sensitive approach and
vision for equity in its quest to leave no one behind, the Agenda is
universal in urging all countries to make progress towards imple-
menting the ideals of human rights and inclusiveness. Yet so
far, multisectoral approaches to tackling neglected tropical dis-
eases (NTDs) have had little more than an episodic focus on gen-
der, equity and ethnic equality, often being considered from a
biomedical standpoint, with a cursory exploration of the complex
sociocultural factors that influence patients’ experience, rang-
ing from susceptibility to living with life-altering morbidity. Indi-
viduals living in vulnerable situations, such as migrant workers,
refugees, indigenous peoples and thosewith physical andmental
disabilities, are often more susceptible to NTD-associated infec-
tion andmorbidity, heightening their potential social exclusion. If
the goals outlined in the WHO 2021–2030 NTD road map are to
be achieved,1 it is vital that those living in situations of vulnera-
bility have the same opportunities to receive NTD treatments as
those living in countries where elimination has already occurred.
Despite the impact of traditional gender roles, little attention
is given to gendered NTD inequalities. Some NTD programmes
have invested in considering gender, but the work is patchy with-
out a holistic view across all NTDs or even within a specific dis-
ease. There are examples of both women and men being left
behind in NTD programmes. For example, women living with
leprosy tend to receive treatment later than men because of
societal and internalised stigmatising attitudes, and the gender
insensitivity of leprosy services. These factors also mean that a
proportion of women with leprosy have yet to be identified at
all.2 Gendered analysis of NTD outcomes for individuals tends
to focus on disease outcomes predominantly for women, with
limited exploration of the illness experience of men and peo-
ple who are non-binary individuals.3 The biological consequences
of NTD infections such as trachoma, schistosomiasis and leish-
maniasis are better understood for women. However, we must
acknowledge that the disabling aspects of some diseases—such
as female genital schistosomiasis, which affects women’s sex-
ual and reproductive health—are gender-specific and known to
be neglected within disease-specific control strategies.4 Other
studies also show that, compared with women, men are less
likely to access community-based treatments for lymphatic filar-
iasis, suggesting that there is a need for gender-sensitive analy-
ses of men’s lives and masculinities in relation to NTDs. Indeed,
masculinity is generally associated with higher health disparities,
with men often preferring to face risk and physical discomfort
rather than be associated with stereotypically ‘feminine’ traits.5
Furthermore, despite some reflections on the impact of gender
on health outcomes for some NTDs, little research has explored
how this influences comorbidities such as mental health,
©World Health Organization, 2021. All rights reserved. The World Health Organization has granted the Publisher permission for the
reproduction of this article. This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 IGO License
(https://creativecommons.org/licenses/by/3.0/igo/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided








h/article/115/2/188/6095748 by guest on 30 M
arch 2021
Transactions of the Royal Society of Tropical Medicine and Hygiene
quality of life and experience through time. Intersectional
research exploring how gender interacts with other axes of
inequality, such as age and education and with broader contex-
tual factors such as conflict and poverty, to shape the NTD expe-
rience, is also limited.
Achieving universal access to interventions against NTDs calls
for new working methods to reach urban populations, con-
flict areas, ethnic minorities and migratory communities.6 These
include new approaches to ensure that newly recognised NTDs
such as snakebite envenoming are not left behind due to oldways
of programming,7 and are supported by new forms of data col-
lection and analysis to identify inequities in health and evaluate
policies and programmes. Current NTD information systems do
not sufficiently capture parameters for health equity influenced
by higher levels of poverty, illiteracy and lack of access to basic
services such as water and sanitation. Nor is there information
on ethnicity collected to understand how different ethnic groups
are affected. These evidence gaps have stymied efforts to move
beyond simply describing disease burdens to tackling the larger
social and structural processes that influence vulnerability across
the NTD continuum from exposure to long-term care.
Programmes based on human rights have been shown to
improve service delivery and enhance equality, equity, inclusive-
ness and accountability. Yet for NTDs, formal mechanisms of
encouraging accountability for inclusion and human rights in NTD
programming are rare, despite initial efforts in the early 2000s.8
Advocacy promoting NTDs as a ‘best buy’ in global health can
hide the larger costs associated with interventions to tackle the
wider determinants of disease. Importantly, many of these hid-
den costs may also be borne by the NTD volunteer workforce,
adding a biased burden to communities. Limited acknowledge-
ment of the full cost of tackling NTDsweakens the transformative
potential of NTD programming.
The NTD 2021–2030 road map presents a paradigm shift,
which calls for increased coimplementation, better integration
with thewider health systemandmore holistic approaches to the
management of NTDs. Without better understanding of the ill-
ness experience associatedwith NTDs and how this varies by axes
of inequality, and between different NTDs, achieving and sustain-
ing the gains from such a paradigm shift will be difficult. The epi-
demiology of NTDs offers pragmatic opportunities to test these
shifts, which should be measured not simply through whether
gender-disaggregated data are being collected and reported, but
by the extent to which programmatic decision-making author-
ity and implementation are ensuring equitable delivery of NTD
services.
Recent approval of seminal policies at the ministry level9
and creation of a new WHO Technical Working Group on gen-
der, equity and human rights for NTDs10 underscore calls to
better understand determinants of health inequities associated
with NTDs. This new momentum should be sustained to support
equitable action against NTDs. Revitalising intersectoral engage-
ment to support equity analyses for national NTD programmes
will be essential. Such joint efforts are needed to attain well-
being for individuals affected by NTDs, both as local and global
citizens.
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